Chi DS

No ORCID on file · 12 papers in corpus · active 2016-2024

Study types

  • article 1

Condition tags

  • endometriosis 1
2024
Gynecologic Oncology ·doi:10.1016/j.ygyno.2024.01.015

ObjectivesMesonephric (MA) and mesonephric-like (MLA) adenocarcinomas are rare cancers, and data on clinical behavior and response to therapy are limited. We sought to report molecular features, treatment, and outcomes of MA/MLA from a sing…

2024
Gynecologic oncology reports ·doi:10.1016/j.gore.2024.101415

BackgroundUterine leiomyomas are benign tumors characterized by pelvic pain and abnormal bleeding. Their evolution can lead to degenerative changes, occasionally mimicking malignancies on imaging, presenting diagnostic challenges.Case prese…

article 2023
Gynecologic oncology ·doi:10.1016/j.ygyno.2023.06.579

OBJECTIVES: To evaluate clinical, laboratory, and radiological variables from preoperative contrast-enhanced computed tomography (CECT) for their ability to distinguish ovarian clear cell carcinoma (OCCC) from non-OCCC and to develop a nomo…

2023
Gynecologic Oncology ·doi:10.1016/j.ygyno.2023.10.013

ObjectiveTo assess the impact of short-term postoperative complications on oncologic outcomes for patients with epithelial ovarian cancer undergoing primary cytoreductive surgery (PCS) or interval cytoreductive surgery (ICS) with intestinal…

2023
European journal of radiology ·doi:10.1016/j.ejrad.2023.111122

PurposeOvarian-Adnexal Reporting and Data System (O-RADS) MRI uses a 5-point scale to establish malignancy risk in sonographically-indeterminate adnexal masses. The management of O-RADS MRI score 4 lesions is challenging, as the prevalence …

2022
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society ·doi:10.1136/ijgc-2022-003935

ObjectiveWe sought to describe clinicopathologic and treatment factors associated with oncologic outcomes in patients with early-stage ovarian clear cell carcinoma undergoing complete staging and in a sub-set of these patients undergoing fe…

2022
JCO oncology practice ·doi:10.1200/op.21.00382

Pathogenic germline variants underlie up to 20% of ovarian cancer (OC) and are associated with varying degrees of risk for OC. For mutations in high-penetrance genes such as BRCA1/2, the role of risk-reducing bilateral salpingo-oophorectomy…

2022
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society ·doi:10.1136/ijgc-2022-003430

BackgroundAlthough immune checkpoint blockade has demonstrated limited effectiveness against ovarian cancer, subset analyses from completed trials suggest possible superior efficacy in the clear cell carcinoma subtype.ObjectiveTo describe t…

2020
Gynecologic Oncology ·doi:10.1016/j.ygyno.2020.07.004

ObjectiveTo evaluate the feasibility of an electronic symptom-tracking platform for patients recovering from ambulatory surgery.MethodWe assessed user response to an electronic system designed to self-report symptoms. Endpoints included com…

2017
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society ·doi:10.1097/igc.0000000000000849

ObjectivesComplete cytoreduction of ovarian cancer often requires excision or ablation of bowel serosa implants. Both argon beam coagulator (ABC) and thermal plasma energy (TPE) (PlasmaJet; PlasmaSurgical, Roswell, Ga) have been used to abl…

2017
Annals of oncology : official journal of the European Society for Medical Oncology ·doi:10.1093/annonc/mdx525

BackgroundWe sought to evaluate the impact of adjuvant chemotherapy on overall survival (OS) in patients with stage I endometrioid epithelial ovarian cancer (EEOC) or ovarian clear cell cancer (OCCC) using a national database.Patients and m…

2016
European radiology ·doi:10.1007/s00330-015-4040-5

PurposeTo determine if second-opinion review of gynaecologic oncologic (GynOnc) magnetic resonance imaging (MRI) by sub-specialized radiologists impacts patient care.Methods469 second-opinion MRI interpretations rendered by GynOnc radiologi…